Page 3 - Compulsory Licensing News Today

This comes even as vaccination speed in the country has almost halved since it was opened for the 18-44 group from May 1, compared to April.

Compulsory licensing for COVID vaccines is not a very attractive option since it is not a formula that matters and other aspects like sourcing of raw materials and training of human resources also need to be taken into consideration, Niti Aayog Member V K Paul said on Thursday. Paul, the Chair of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), noted that technology transfer is the key and that remains in the hands of the company that has carried out R&D. The govern...

The Tamil Nadu government should take over the HLL Biotech Ltds integrated vaccine complex at Chengalpattu by bidding successfully and ask Bharat Biotech Ltd to fill and pack its Covaxin vaccine for Covid-19, suggests group of noted ...

‘Other vaccine developers must transfer technology to Indian companies against reasonable royalties’

FICCI supportive of ‘TRIPS waiver’ proposal to ramp up COVID-19 vaccines manufacturing FICCI supportive of ‘TRIPS waiver’ proposal to ramp up COVID-19 vaccines manufacturing 13 May 2021 | News The immediate focus has to be on connecting with the ‘right’ global companies to facilitate ‘technology transfer’ and voluntary licenses to Indian companies Source credit: Shutterstock FICCI is encouraged by the US support for the ‘TRIPS waiver’ proposa...

Technology Transfer and Voluntary Licenses will help to improve vaccine supply:

Focus on technology transfer, voluntary licenses to Indian companies to address vaccine shortage: FICCI SECTIONS Share Synopsis The immediate focus has to be on connecting with the right global companies to facilitate technology transfer and voluntary licenses to Indian companies that have the capacity and capability for mass-production of COVID vaccines, FICCI said. Reuters Representative Image The government should work on war-footing to alleviate the shortage of vaccines in the country which...

US pharma giant Eli Lilly has issued royalty-free, non-exclusive voluntary licences to three Indian drug makers – Cipla, Sun Pharmaceuticals and Lupin – to manufacture and distribute Baricitinib, which is being used to treat Covid-19. Earlier, Gilead too had signed non-exclusive voluntary licensing agreements with Indian pharmaceutical companies to expand the production of Remdesivir, a widely used anti-Covid drug. “The voluntary licensing agreements will ensure high-quality manufacturing...

India News: NEW DELHI: The Left parties on Saturday lashed out at the government, accusing it of wasting time in preparing for the Covid pandemic and said that if.

Scaling Up Vaccine Production: Why Compulsory Licensing Isnt The Silver Bullet That It Might Appear To Be by Ananth Krishna - May 11, 2021 07:32 AM Covid-19 vaccine doses Snapshot Even if the government were to grant other companies the licence to manufacture Covaxin, they woudnt be able to start production anytime soon. The Supreme Court on 30 April 2021, while dealing with the suo moto petition regarding the management of Covid-19 in India asked why compulsory licensing cannot be invoked un...